Advertisement AMIC and University of Missouri sign development agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

AMIC and University of Missouri sign development agreement

Advanced Medical Isotope Corporation has entered into an agreement for the development of a compact device to produce radioisotopes with the University of Missouri.

The University of Missouri (MU) holds intellectual property for a system than can generate clinically relevant quantities of radioisotopes (including Mo-99), the production of which normally requires a nuclear reactor. This can be done in a ‘sub-critical system’ with an infrastructure footprint similar to a commercial cyclotron facility.

The partnership between MU and Advanced Medical Isotope Corporation (AMIC) allows for a staged development of such a system to produce medical, research and industrial isotopes. MU currently holds intellectual property for a device that generates neutrons in a tank filled with heavy water and fissile uranium material.

Robert Schenter, chief science officer for AMIC, said: “This proposed device is a response to the limitations of the current model of production and delivery of radioisotopes that require neutrons to either create fission products or to irradiate stable targets.”